A pharmacist administering a dose of the Moderna  vaccine in Washington, DC. Photograph: Eric Lee/Bloomberg

Moderna reported its first ever quarterly profit as it sold $1.7 billion (€1.4 bn) worth of Covid-19 vaccines in the first three months of the year, a(...)

The results of the small trial of the Moderna Covid-19 vaccine suggest that boosters against the variants will be feasible. File photograph: Joseph Prezioso/AFP via Getty Images

The first “tweaked” vaccine against the worrying coronavirus variants that emerged in South Africa and Brazil has successfully neutralised them in lab(...)

Photograph: iStock

Moderna said it would produce as many as 3 billion doses of its Covid-19 vaccine next year as it makes new investments to bolster output at several fa(...)

The EU Commission has agreed a deal for 150 million additional doses of the Moderna vaccine for delivery this year.

Millions of extra Covid-19 vaccine doses have been secured for Ireland this year under new European Union deals, with planning underway to potentially(...)

Both the Moderna and Pfizer vaccines rely on a technology called messenger RNA that turns the body’s cells into vaccine-making factories.

US company Moderna said it plans to request clearance for its coronavirus vaccine in the United States and Europe on Monday, after a new analysis show(...)

US pharma companies Moderna and Pfizer, with its German partner BioNTech have launched major Phase III trials of their Covid vaccine candidates. Photograph: Hans Pennink/AP

German biotech BioNTech and US drugmaker Pfizer will begin a pivotal global study of 30,000 people to evaluate their lead Covid-19 vaccine candidate. (...)

Initial results show that an experimental Covid-19 vaccine from Moderna shows promise in a small early-stage trial.

Early data from Moderna’s Covid-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small gro(...)

A pharmacist gives Jennifer Haller (L) the first shot in the first-stage safety study clinical trial of a potential vaccine for Covid-19, at the Kaiser Permanente Washington Health Research Institute in Seattle. Photograph: AP Photo/Ted S. Warren

The first testing in humans of an experimental vaccine for coronavirus, also known as Covid-19, began Monday, the National Institute of Allergy and In(...)

Scientist Xinhua Yan works in the lab at Moderna in Cambridge, MA.  Photograph: David L. Ryan/The Boston Globe

Juan Andres woke up three times during the night after putting his precious vials of vaccine on the back of a delivery lorry. In late February, Modern(...)